3Fraunfelder FW. Corneal toxicity from topical ocular and systemic medications [ J ]. Cornea, 2006,25 : 1133-1138.
4Lin JC, Rapuano C J, Laibson PR, et al. Corneal mehing associated with use of topical nonsteroidal anti-intlamma- tory drugs after ocular surgery [ J ]. Arch Ophthalmol , 2002, 118:1129-1132.
5Rosenberg ME, Tervo TM, Immonen IJ, et al. Corneal structure and sensitivity in type I diabetes mellitus [ J ]. Visual Science, 2010, 41:2915-2921.
6Ngamjit K,Vannarut S,Theerapa C,et al.Incidence and Pattern of Dry Eye after Cataract Surgery[J].PLo S One,2013,8(11):e78657.
7Schiffman RM,Christianson MD,Jacobsen G,et al.Reliability and validity of the Ocular Surface Disease Index[J].Arch Ophthalmol,2000,118:615-621.
8Fuller DG,Potts K,Kim J.Noninvasive tear breakup times and ocular surface disease[J].Optom Vis Sci,2013,90(10):1086-1091.
9Nelson JD,Shimazaki J,Benitez-del-Castillo JM,et al.The international workshop on meibomian gland dysfunction:report of the definition and classification subcommittee[J].Invest Ophthalmol Vis Sci,2011,52(4):1930-1937.
10Moss SE,Klein R,Klein BE.Long-term incidence of dry eye in an older population[J].Optom Vis Sci,2008,85:668-674.
